Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03600441
Title Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma (FORERUNNER)
Acronym FORERUNNER
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xynomic Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.